| 期刊全稱 | Biomarkers for Endometriosis | | 期刊簡(jiǎn)稱 | State of the Art | | 影響因子2023 | Thomas D‘Hooghe | | 視頻video | http://file.papertrans.cn/188/187797/187797.mp4 | | 發(fā)行地址 | Summarizes the latest diagnostic performance of non- or semi-invasive tests for endometriosis.Reviews the key current research and developments of biomarkers in related fields.Explores the future deve | | 圖書(shū)封面 |  | | 影響因子 | This book presents an overview of the diagnostic performance of non- or semi-invasive tests for endometriosis in peripheral blood, endometrium, saliva, peritoneal fluid and urine. The value of existing and emerging systems biology technologies for biomarker development is addressed in several chapters on genetics, microarrays, proteomics and metabolomics. Although tests with high sensitivity and acceptable specificity have been developed, sometimes validated in independent populations and seem promising, more research is needed to translate these data into clinical benefit for patients and coordinate efforts internationally to standarize analysis, reports and operating procedures. The gold standard to diagnose endometriosis is currently through laparoscopic inspection with histological confirmation, a surgical procedure with rare but significant potential risks for the patients. A non-invasive test for endometriosis would be critical for the early detection of endometriosis of symptomatic women with pelvic pain and/or subfertility with normal ultrasound. This would include nearly all cases of minimal-mild endometriosis, some cases of moderate-severe endometriosis without a clearly | | Pindex | Book 2017 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-8 02:37
發(fā)表于 2025-3-21 19:21:07
